Platelet absorption of ELISA-detectable DDABs
| . | Δ (no depletion) . | Percentage depletion (minus roxifiban) . | Percentage depletion (plus roxifiban) . |
|---|---|---|---|
| 21013 | 617 | 0 | 77 |
| 49007 | 57 | 0 | 100 |
| 61003 | 64 | 6 | 93 |
| 7013 | 74 | 15 | 100 |
| . | Δ (no depletion) . | Percentage depletion (minus roxifiban) . | Percentage depletion (plus roxifiban) . |
|---|---|---|---|
| 21013 | 617 | 0 | 77 |
| 49007 | 57 | 0 | 100 |
| 61003 | 64 | 6 | 93 |
| 7013 | 74 | 15 | 100 |
Citrated plasma obtained from the indicated patients was tested by the DDAB ELISA (Δ [no depletion]). Parallel samples were incubated with washed platelets in the absence (minus) or presence (plus) of roxifiban. Plasma was recovered by centrifugation and analyzed by the DDAB ELISA. Results are expressed as percentage depletion compared with the samples not treated with platelets.